Integra LifeSciences Sees Modest Orthopedic Growth from Dedicated Sales Channel

Integra LifeSciences reported 3Q19 orthopedic revenue of USD $20.9MM, +1.6% vs. 3Q18.

In 3Q19, the company’s orthopedic business grew in the low single digits globally, with U.S.  growth of nearly 7%
Combined sales of ankle and shoulder products grew nearly 20% for the quarter, driven by the Titan Reverse Shoulder, improved...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us